Ardelyx (ARDX) News Today $4.97 +0.26 (+5.52%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Ardelyx, Inc. (NASDAQ:ARDX) Given Average Rating of "Moderate Buy" by AnalystsShares of Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) have earned an average recommendation of "Moderate Buy" from the eight brokerages that are covering the company, Marketbeat reports. Two investment analysts have rated the stock with a hold recommendation, five have assigned a buy recommendatNovember 17 at 1:30 AM | marketbeat.comArdelyx (NASDAQ:ARDX) Shares Gap Up - Here's WhyNovember 17 at 1:27 AM | americanbankingnews.comArdelyx (NASDAQ:ARDX) Shares Gap Up - Time to Buy?Ardelyx (NASDAQ:ARDX) Shares Gap Up - What's Next?November 15 at 12:19 PM | marketbeat.comArdelyx's Medicare Setback Casts Doubt On Long-Term ViabilityNovember 14 at 10:05 AM | seekingalpha.comArdelyx (NASDAQ:ARDX) Cut to "Neutral" at HC WainwrightNovember 14 at 2:49 AM | americanbankingnews.comHC Wainwright Issues Negative Estimate for Ardelyx EarningsNovember 14 at 2:01 AM | americanbankingnews.comArdelyx, Inc. (NASDAQ:ARDX) CEO Sells $13,440.70 in StockNovember 13, 2024 | insidertrades.comResearch Analysts Set Expectations for Ardelyx Q1 EarningsArdelyx, Inc. (NASDAQ:ARDX - Free Report) - Stock analysts at HC Wainwright decreased their Q1 2025 earnings estimates for shares of Ardelyx in a research report issued to clients and investors on Monday, November 11th. HC Wainwright analyst E. Arce now anticipates that the biopharmaceutical compNovember 13, 2024 | marketbeat.comHC Wainwright & Co. Downgrades Ardelyx (ARDX)November 12, 2024 | msn.comArdelyx downgraded to Neutral from Buy at H.C. WainwrightNovember 12, 2024 | markets.businessinsider.comArdelyx down as H.C. Wainwright downgrades rating on anticipated Xphozah sales dropNovember 12, 2024 | msn.comArdelyx (NASDAQ:ARDX) Sees Unusually-High Trading Volume - What's Next?Ardelyx (NASDAQ:ARDX) Sees Large Volume Increase - Time to Buy?November 11, 2024 | marketbeat.comArdelyx (NASDAQ:ARDX) Rating Lowered to Neutral at HC WainwrightHC Wainwright downgraded Ardelyx from a "buy" rating to a "neutral" rating and dropped their price objective for the stock from $11.00 to $5.50 in a report on Monday.November 11, 2024 | marketbeat.comArdelyx (NASDAQ:ARDX) Shares Gap Down Following Insider SellingNovember 10, 2024 | americanbankingnews.comArdelyx down 21% to $5.30 after judge dismisses lawsuit against CMSNovember 9, 2024 | markets.businessinsider.comArdelyx tumbles as lawsuit against CMS dismissed over Xphozah (update)November 9, 2024 | msn.comInsider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 27,171 Shares of StockNovember 9, 2024 | insidertrades.comDavid P. Rosenbaum Sells 27,171 Shares of Ardelyx, Inc. (NASDAQ:ARDX) StockArdelyx, Inc. (NASDAQ:ARDX - Get Free Report) insider David P. Rosenbaum sold 27,171 shares of the stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $6.10, for a total value of $165,743.10. Following the completion of the sale, the insider now directly owns 153,616 shares of the company's stock, valued at approximately $937,057.60. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.November 8, 2024 | marketbeat.comArdelyx Responds to District Court Decision Granting Motion to DismissNovember 8, 2024 | globenewswire.comArdelyx (NASDAQ:ARDX) Shares Gap Down - What's Next?Ardelyx (NASDAQ:ARDX) Shares Gap Down - Time to Sell?November 8, 2024 | marketbeat.comInsider Selling: Ardelyx, Inc. (NASDAQ:ARDX) Insider Sells 27,172 Shares of StockNovember 7, 2024 | insidertrades.comCitigroup Cuts Ardelyx (NASDAQ:ARDX) Price Target to $10.00November 7, 2024 | americanbankingnews.comArdelyx’s Strong Sales and Strategic Positioning Reinforce Buy Rating Amid Reimbursement UncertaintiesNovember 5, 2024 | markets.businessinsider.comArdelyx to Participate at the 2024 Jefferies London Healthcare ConferenceNovember 5, 2024 | globenewswire.comCitigroup Has Lowered Expectations for Ardelyx (NASDAQ:ARDX) Stock PriceCitigroup cut their price objective on Ardelyx from $12.00 to $10.00 and set a "buy" rating on the stock in a research report on Monday.November 4, 2024 | marketbeat.comWedbush Research Analysts Cut Earnings Estimates for ArdelyxArdelyx, Inc. (NASDAQ:ARDX - Free Report) - Equities research analysts at Wedbush reduced their FY2026 earnings per share estimates for Ardelyx in a report issued on Friday, November 1st. Wedbush analyst L. Chico now expects that the biopharmaceutical company will post earnings per share of $0.06November 4, 2024 | marketbeat.comArdelyx, Inc.: Ardelyx Reports Third Quarter 2024 Financial Results and Provides Business UpdateNovember 3, 2024 | finanznachrichten.deArdelyx Third Quarter 2024 Earnings: US$0.003 loss per share (vs US$0.03 profit in 3Q 2023)November 3, 2024 | finance.yahoo.comArdelyx, Inc. (NASDAQ:ARDX) Q3 2024 Earnings Call TranscriptNovember 2, 2024 | msn.comQ3 2024 Ardelyx Inc Earnings CallNovember 2, 2024 | finance.yahoo.comArdelyx (ARDX) Receives a Buy from WedbushNovember 2, 2024 | markets.businessinsider.comArdelyx Surpasses Q3 Revenue EstimatesNovember 1, 2024 | fool.comArdelyx: Strong Sales Growth and Reimbursement Prospects Justify Buy RatingNovember 1, 2024 | markets.businessinsider.comArdelyx price target raised to $13.50 from $12.50 at LadenburgNovember 1, 2024 | markets.businessinsider.comArdelyx (NASDAQ:ARDX) Earns "Buy" Rating from HC WainwrightHC Wainwright restated a "buy" rating and set a $11.00 price objective on shares of Ardelyx in a research note on Friday.November 1, 2024 | marketbeat.comArdelyx (NASDAQ:ARDX) Trading Up 7.3% - What's Next?Ardelyx (NASDAQ:ARDX) Stock Price Up 7.3% - Time to Buy?November 1, 2024 | marketbeat.comArdelyx Target of Unusually High Options Trading (NASDAQ:ARDX)Ardelyx, Inc. (NASDAQ:ARDX - Get Free Report) saw unusually large options trading on Friday. Stock investors purchased 5,573 call options on the company. This represents an increase of 75% compared to the average daily volume of 3,185 call options.November 1, 2024 | marketbeat.comArdelyx, Inc. (NASDAQ:ARDX) CEO Sells 25,000 Shares of StockNovember 1, 2024 | insidertrades.comArdelyx's Earnings OutlookNovember 1, 2024 | benzinga.comArdelyx’s Robust Market Performance and Strategic Initiatives Justify Buy RatingNovember 1, 2024 | markets.businessinsider.comArdelyx Inc (ARDX) Q3 2024 Earnings Call Highlights: Revenue Surge and Strategic Growth Amidst ...November 1, 2024 | finance.yahoo.comArdelyx Reports Robust Q3 2024 Revenue GrowthNovember 1, 2024 | markets.businessinsider.comArdelyx Reports Third Quarter 2024 Financial Results and Provides Business UpdateOctober 31, 2024 | globenewswire.comArdelyx, Inc. (NASDAQ:ARDX) CEO Sells $147,750.00 in StockArdelyx, Inc. (NASDAQ:ARDX - Get Free Report) CEO Michael Raab sold 25,000 shares of the company's stock in a transaction that occurred on Monday, October 28th. The stock was sold at an average price of $5.91, for a total transaction of $147,750.00. Following the completion of the transaction, the chief executive officer now owns 1,210,108 shares of the company's stock, valued at approximately $7,151,738.28. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.October 31, 2024 | marketbeat.comArdelyx Inc.October 30, 2024 | wsj.comArdelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology’s (ACG) Annual MeetingOctober 28, 2024 | finance.yahoo.comArdelyx Presents Results from its IBS in America 2024 Supplemental Survey at the American College of Gastroenterology's (ACG) Annual MeetingOctober 28, 2024 | globenewswire.comArdelyx announces presentation of Xphozah data at Kidney WeekOctober 25, 2024 | markets.businessinsider.comArdelyx Shares Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) at the American Society of Nephrology’s Kidney WeekOctober 25, 2024 | markets.businessinsider.comPiper Sandler Reaffirms Their Hold Rating on Ardelyx (ARDX)October 24, 2024 | markets.businessinsider.com Get Ardelyx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Why buying gold might be a mistake (Ad)Something strange just happened with gold. With the recent Fed rate cut… My charts are showing a breakout signal I haven't seen in years. But for now, I'm not rushing to buy gold. In fact, I'm telling everyone I know to hold off. Because I believe there’s a far better way to play this upcoming surge. It's a method that could turn a 1% gold price change into gains like 59%, 118%, or even 228%. And it doesn't involve buying a single ounce of physical gold or even buying any regular gold stock. I've been trading gold for nearly 20 years now and this is my #1 recommended approach for trading gold right now. Most traders miss them completely… But for those who know how to spot them, it takes their trades to a whole new level. If you're interested, check out the recording here while the link's still up. ARDX Media Mentions By Week ARDX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARDX News Sentiment▼0.030.56▲Average Medical News Sentiment ARDX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARDX Articles This Week▼208▲ARDX Articles Average Week Get Ardelyx News Delivered to You Automatically Sign up to receive the latest news and ratings for ARDX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies OPK News Today MIRM News Today XBIT News Today RNA News Today KRYS News Today BBIO News Today BHVN News Today RARE News Today ACLX News Today CRNX News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARDX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ardelyx, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Ardelyx With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
